Bioline Rx Ltd (ADR) - BLRX - stock price prediction, stock price target, analyst ratings from 1 analyst

Bioline Rx Ltd (ADR) has a share price target of US$ 18, revenue growth forecast of 50.8%, and profit growth estimate of -1062.7% for FY26, based on top 1 analyst call.